Anixa Biosciences Inc (NASDAQ:ANIX)
| 3.27 Delayed Data As of Feb 26 |  +0.04 / +1.24%Today’s Change | 2.74 Today|||52-Week Range 5.47 | -0.30% Year-to-Date |
Latest ANIX News | Press Releases
No recent news for Anixa Biosciences Inc.
Today’s Trading
| Previous close | 3.23 |
| Today’s open | 3.20 |
| Day’s range | 3.13 - 3.27 |
| Volume | 32,012 |
| Average volume (3 months) | 62,316 |
| Market cap | $70.4M |
Data as of 3:59pm ET, 02/26/2020
Growth & Valuation
| Earnings growth (last year) | +25.89% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -77.53% |
| P/E ratio | NM |
| Price/Sales | 306.35 |
| Price/Book | 13.86 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ETTXEntasis Therapeutics... | +0.01 | +0.28% |
| MBOTMicrobot Medical Inc | -0.10 | -1.04% |
| AQBAquaBounty Technolog... | -0.18 | -8.87% |
| MITOStealth BioTherapeut... | -0.02 | -1.01% |
Data as of 4:00pm ET, 02/26/2020
Financials
| Next reporting date | March 10, 2020 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $250.0K |
| Annual profit (last year) | -$11.6M |
| Net profit margin | -4,658.82% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Jose, California |
Forecasts
